Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Hemorrhage 1Colonic Neoplasms 1

Interventions

Sorafenib 3lenvatinib 2sintilimab 1pembrolizumab 1halofantrine 1glucose-regulated proteins 1camrelizumab 1Tranexamic Acid 1Thalidomide 1Sunitinib 1Standard of Care 1Saline Solution 1Oxaliplatin 1Nadroparin 1Lidocaine 1Injections 1Immune Checkpoint Inhibitors 1Heparin, Low-Molecular-Weight 1Gemcitabine 1Folfox protocol 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Liver Neoplasms × Tranexamic Acid × Clear all
NCT01655641 2012-10-16

TMGS

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Phase 2/3 Unknown
118 enrolled
Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡